Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT04384484 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04384484
- Sponsor
- ADC Therapeutics S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2026-03-31
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.